Simoni M, Weinbauer G F, Gromoll J, Nieschlag E
Institute of Reproductive Medicine of the University, Münster, Germany.
Ann Endocrinol (Paris). 1999 Jul;60(2):102-6.
The production of male gametes depends on the concerted action of the two gonadotropins FSH and LH on the testis. The action of LH is mediated through the production of testosterone by the Leydig cells. Since male germ cells possess neither FSH nor androgen receptors, the action of FSH and testosterone occurs through the Sertoli cells. Although the precise function of these two hormones remains elusive, the existing evidence suggest that both FSH and testosterone are able to stimulate all phases of spermatogenesis. In the male FSH is required for the determination of Sertoli cell number, and for induction and maintenance of normal sperm production. The crucial role of FSH in male gonadal function has been clearly illustrated by the discovery of a patient with an activating mutation of the FSH receptor. This patient had been hypophysectomized because of a pituitary tumor and, under testosterone substitution was unexpectedly fertile in spite of undetectable serum gonadotropin levels and had fathered three children. In this patient we could demonstrate a heterozygous activating mutation of the FSH receptor which resulted in cAMP production independent of FSH stimulation. This finding represents the first description of an activating mutation of the FSH receptor and demonstrates that FSH alone maintains spermatogenesis in man. On the other hand, the effects of the lack of FSH action are unclear. Among five men with a homozygous inactivating mutation of the FSH receptor only one was infertile and spermatogenesis was variably affected in the others. However, serum inhibin B values in these men were not completely suppressed and serum FSH levels were only moderately elevated, indicating the possibility that FSH receptor function was not completely abolished by the mutation. Elimination of FSH action is a prerequisite to suppress completely spermatogenesis for contraceptive purposes, while administration of both LH and FSH is necessary to induce sperm production in patients with hypogonadotropic hypogonadism. Experimental immunization of male monkeys against FSH markedly reduced germ cell proliferation and even induced infertility. At the cellular level, FSH stimulates the cAMP-dependent activation of protein kinase A in Sertoli cells, but the molecular mechanism of FSH action is poorly understood. In the primate, the gonadotropin withdrawal achieved by administration of a GnRH antagonist leads to a premeiotic arrest of germ cell proliferation, probably due to inhibition of the mitotic division of A-pale spermatogonia. Therefore, FSH might be the prime inducer of spermatogonial proliferation, while the successive maturation process could proceed independently of FSH. In summary, clinical and experimental evidence support the concept of an irreplaceble role of FSH in the primate. Only the combination of FSH and testosterone, however, supports a qualitatively and quantitatively fully normal spermatogenesis.
雄性配子的产生依赖于两种促性腺激素——促卵泡激素(FSH)和促黄体生成素(LH)对睾丸的协同作用。LH的作用是通过睾丸间质细胞产生睾酮来介导的。由于雄性生殖细胞既不具有FSH受体也不具有雄激素受体,FSH和睾酮的作用是通过支持细胞来实现的。尽管这两种激素的确切功能仍不清楚,但现有证据表明,FSH和睾酮都能够刺激精子发生的各个阶段。在雄性中,FSH对于确定支持细胞数量以及诱导和维持正常精子产生是必需的。FSH受体激活突变患者的发现清楚地说明了FSH在雄性性腺功能中的关键作用。该患者因垂体肿瘤接受了垂体切除术,在睾酮替代治疗下,尽管血清促性腺激素水平检测不到,但仍意外地具有生育能力,并育有三个孩子。在该患者中,我们能够证明FSH受体的杂合激活突变,该突变导致了不依赖FSH刺激的环磷酸腺苷(cAMP)产生。这一发现首次描述了FSH受体的激活突变,并证明仅FSH就能维持人类的精子发生。另一方面,FSH作用缺乏的影响尚不清楚。在五名具有FSH受体纯合失活突变的男性中,只有一人不育,其他人的精子发生受到不同程度的影响。然而,这些男性的血清抑制素B值并未完全被抑制,血清FSH水平仅中度升高,这表明该突变可能并未完全消除FSH受体功能。消除FSH作用是为了避孕而完全抑制精子发生的前提条件,而对于低促性腺激素性性腺功能减退患者,给予LH和FSH对于诱导精子产生是必要的。对雄性猴子进行FSH实验性免疫显著降低了生殖细胞增殖,甚至导致不育。在细胞水平上,FSH刺激支持细胞中蛋白激酶A的cAMP依赖性激活,但对FSH作用的分子机制了解甚少。在灵长类动物中,通过给予促性腺激素释放激素(GnRH)拮抗剂实现的促性腺激素撤退导致生殖细胞增殖在减数分裂前期停滞,这可能是由于抑制了A-淡色精原细胞的有丝分裂。因此,FSH可能是精原细胞增殖的主要诱导因子,而后续的成熟过程可能独立于FSH进行。总之,临床和实验证据支持FSH在灵长类动物中具有不可替代作用的概念。然而,只有FSH和睾酮的联合作用才能支持质量和数量上完全正常的精子发生。